AI assistant
Sending…
Assertio Holdings, Inc. — Director's Dealing 2020
May 22, 2020
34279_dirs_2020-05-21_4bf57194-a8ce-4b36-a41b-e817e9c7639f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Assertio Holdings, Inc. (ASRT)
CIK: 0001808665
Period of Report: 2020-05-19
Reporting Person: Peisert Daniel A. (EVP and CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-19 | Stock Options | $0.8 | A | 200000 | Acquired | 2030-05-19 | Common Stock (200000.0) | Direct |
| 2020-05-19 | Restricted Stock Units | $ | A | 100000 | Acquired | Common Stock (100000.0) | Direct |
Footnotes
F1: As a result of a holding company reorganization effective May 19, 2020, Assertio Holdings, Inc., is the successor issuer to Assertio Therapeutics, Inc., pursuant to 12g-3(a) of the Exchange Act.
F2: These options vest in full on May 19, 2021.
F3: Each restricted stock unit represents a contingent right to receive one share of the registrant's common stock.
F4: These restricted stock units are scheduled to vest in full on May 19, 2021.
More from Assertio Holdings, Inc.
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 29
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 9